In the private sector, compliance programmes focus mainly on preventing and detecting acts and acts of corruption. In some organisations, depending on the resources available, the compliance programme may also cover competition law compliance, personal data protection, export control or money laundering prevention.
A compliance programme in the private sector is generally built on three main pillars: prevention, assessment and detection of possible non-compliance and the response you have as an organisation when deviations are found.
Prevention means providing clear rules by which to conduct your business. Any private company has, first and foremost, a number of obligations in the area of integrity arising from regulatory acts. However, where the law does not provide for clear conduct, self-regulation comes into play. In the pharmaceutical industry, for example, there are a number of principles agreed and endorsed by companies globally and which are cascaded down to European and national level through codes of conduct and ethical codes applicable to interactions with healthcare professionals, healthcare organisations and patient organisations. Interactions between the pharmaceutical industry and healthcare professionals have a profound and positive influence on the quality of healthcare, patient treatment and research activities. Such interactions are normal, but it is precisely these that are most vulnerable.
Afis-AOSR-Aprilie-2023